Vertex Pharma to Seek Speedy FDA Approval for Kidney Disease Drug From $4.9B Acquisition
Povetacicept, a Vertex Prescription drugs immunology drug designed to dam two targets, met the principle purpose of a Section 3 ...
Tag: 4.9B
Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major Player in Obesity Drugs & More
Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!